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Introduction
In March 2020, in all Italian Regions, the COVID-19 
emergency prompted suspension of all outpatient ser-
vices in the Prevention Departments of the Local Health 
Units, with the sole exception of urgent or non-defer-
rable activities. Most vaccinations were therefore sus-
pended (unless urgent or scheduled for children aged 0-6 
years) [1].
In this context, new strategies were required, in order to 
deal with the backlog of postponed appointments as soon 
as the COVID-19 epidemiological scenario would allow 
at least partial resumption of routine healthcare services. 
For this purpose, the World Health Organization (WHO) 
provided some guiding principles for routine immuniza-
tion activities during the pandemic [2, 3]. On the basis 
of these, the Veneto Region (in North-Eastern Italy) also 
provided its Local Health Units with guidelines for the 
management of the activities of Prevention Departments 
during the so-called “phase 2” of the pandemic  [4]. 
These guidelines included recommendations to: en-
sure hygiene, ventilation, and social distancing among 
healthcare workers and children in waiting rooms and in 
the rooms devoted to vaccination; minimize the number 
of rooms visited by combining medical examinations 
and vaccination during the same visit; specifically train 
the dedicated healthcare personnel; allocate separate ar-
eas for immunization services in hospitals, if possible; 
and temporarily avoid mass vaccination campaigns. 
In this scenario, drive-through vaccination has emerged 
as a rapid and safe means of immunizing large numbers 
of young people and adults whose vaccinations were 
due in the full pandemic period (March-May 2020) and 
whose appointments had to be rescheduled. This innova-
tive modality had previously been experimented inter-
nationally for vaccinations [5, 6], and has recently been 
widely adopted for the administration of swab tests for 
COVID-19 [7-9].
Here, we describe the experience of the Province of Bel-
luno (Veneto Region), a vast alpine territory where over 
12,000 people have been vaccinated against tick-borne 
encephalitis (TBE) since the beginning of summer by 
means of the drive-through modality.
Methods
Context
The Province of Belluno, in the Veneto Region, is a 
mountainous territory in the Alps, in North-eastern It-
aly, with a population of 201,972. In the period 2006-
2018, 153 cases of TBE were notified in this territory, 
with a mean incidence rate (IR) of 5.89 cases/100,000 
inhabitants during the decade 2007-2017; the area is 
therefore defined as “high endemic” (IR > 5/100,000). 
Most cases are notified between April and October, and 
males between 50 and 70 years old are most frequently 
involved. However, it must be pointed out that milder 
cases, which constitute the vast majority, are largely un-
der-diagnosed [10] and that the cases of TBE reported in 
the Province of Belluno account for approximately 40% 
of all Italian cases.
Therefore, since 2019, the Local Health Unit (AULSS 
1 “Dolomiti”) has offered anti-TBE vaccination free of 
charge to all residents who request it [11].
Furthermore, from the end of February to the first week 
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of September 2020, 1,281 cases of COVID-19 were de-
tected in the Province of Belluno [12], with an IR of 634 
positive cases/100,000 inhabitants.
Logistics and organization
Subjects were invited to attend for anti-TBE vaccination 
according to priorities defined on the basis of the preex-
isting waiting list. Priority was given to:
• subjects who should have received the 1st dose of 
vaccine during the lock-down;
• categories exposed to occupational risks who were 
waiting for the 2nd or 3rd dose of vaccine;
• individuals who were already on the waiting list, but 
not yet scheduled to receive the 1st dose of vaccine;
• new requests for appointments for the 1st dose of vac-
cine;
• people waiting for their 2nd dose appointment to be 
scheduled;
• those waiting for their 3rd dose appointment to be 
scheduled.
During each session, appointments were initially sched-
uled at a rate of one every five minutes. Subsequently, the 
high volume of requests made it necessary to schedule 
one appointment every two minutes, in order to vaccinate 
approximately 30 people per hour, and finally one every 
minute. The appointments were communicated by tel-
ephone or letter, together with the following information:
• date and time of the scheduled convocation; 
• specification that it was compulsory to come by car 
and to wear a face mask; 
• recommendation to wear clothing, preferably a t-
shirt, that would facilitate injection of the vaccine;
• description of the exact route to the vaccination site 
and of the subsequent way out; 
• obligation to wait for 15 minutes in a dedicated car 
park after administration of the vaccine, without 
wearing a face mask, in order to enable the super-
vising operator to recognize pallor or other signs of 
adverse events.
The drive-through vaccination site was a tent, gener-
ally provided by local volunteers, equipped with all the 
standard equipment of an in-hospital ambulatory setting:
• refrigerator (2-8°C) for the correct storage of the 
vaccine for the entire duration of the daily activity, 
equipped with separate compartments for pediatric 
doses and adult doses;
• desk and chairs;
• photocopies of a sufficient number of pre-vaccina-
tion anamnestic questionnaires;
• two computers endowed with the Region’s official 
software (SiaVr) for vaccinations, correctly installed 
and functioning;
• two trolleys carrying the vaccine administration ma-
terial;
• emergency trolley;
• wheelchair and stretcher in case a patient needed to 
be transferred from his/her car into the drive-through 
tent;
• containers for special waste and for other waste, ac-
cording to the various disposal needs;
• rigid needle containers;
• at least one kidney-shaped basin for each trolley;
• sanitizing gel;
• gauze and disinfectant.
Before each vaccination session, the personnel were re-
sponsible for checking that the above-listed material was 
present in an adequate quantity. During each session, a 
medical doctor had to be available - either physically 
present at the drive-through site (if this was far from 
the local hospital) or able to reach the site rapidly in the 
event necessity (if the site was within the perimeter of 
the local hospital). The remaining personnel consisted 
of two healthcare assistants or nurses, one of whom ad-
ministered the pre-vaccination questionnaire and regis-
tered each vaccination on the regional software, while 
the other administered the vaccine. An auxiliary opera-
tor patrolled the post-vaccination parking area to check 
for the possible occurrence of adverse reactions.
In the event of any adverse reaction, the three operators 
were trained to transfer the patient immediately from 
his/her car to the wheelchair or stretcher, and then to 
convey him/her promptly to the tent or to the emergency 
room, according to the severity of the clinical symptoms.
The personnel responsible for the procurement of vac-
cines had to request the vaccine doses from the hospital 
pharmacy, possibly well in advance, in accordance with 
the schedule of vaccination sessions, in order to avoid 
any shortage.
Three sites were designated for the drive-through vac-
cinations: 
1. one in the car park (Fig. 1) outside San Martino local 
hospital in Belluno (the Province’s largest town);
2. one in the market square of the small town of Pieve di 
Cadore (less than 5 minutes from the local hospital), 
by agreement with the local municipal administra-
tion; 
3. one in the car park outside the offices of the Preven-
tion Department in the town of Feltre (the second-
largest town in the Province).
A fourth site, in the small town of Caprile, was being 
opened at the time when this article was written. Each 
of the four locations had previously been inspected by 
technicians and IT specialists from the Local Health Unit 
and by the Hygiene and Public Health Service, in order 
to evaluate the spaces available, check the electricity sup-
ply and Internet connection, and determine the pathways 
through and the positioning of the vaccination sites.
Fig. 1. Drive-through site outside San Martino Hospital in Belluno; 
right: a line of cars queuing before vaccination; left: the tent; 
center: cars parked after vaccination.
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Results
By the end of August 2020, a total of 12,152 doses of 
vaccine against TBE (first, second, third and booster 
doses) had been administered to 12,083 people at the 
various sites in the Province of Belluno (Tab. I):
• a total of 8,284 doses administered to 8,193 people 
(91 people received the first and the second doses 
within the period) in Belluno since the 24th June 
2020, in 43 sessions (average of 193 vaccinations per 
day);
• a total of 2,193 doses administered in Pieve di Ca-
dore since the 20th July in 12 sessions (average of 
183 vaccinations per day);
• a total of 1,697 doses administered in Feltre on three 
Sundays during all-day (8 am – 7 pm) sessions.
Overall, in 2020, 18,846 doses of vaccine against TBE 
have been administered, including 6,694 doses admin-
istered in outpatient departments at the beginning of the 
year, before the lock-down, and 12,152 doses administered 
up to the end of August in the drive-through modality. 
These figures compare favorably with those recorded 
in the previous year: indeed, after May 2019, when the 
free-of-charge TBE vaccination was introduced, 8960 
inhabitants of the province received at least one dose of 
vaccine and 13,494 doses were administered overall in 
2019, according to the regional database.
Adverse events 
No major adverse events occurred. As for minor events, 
two cases of pre-syncope and two of syncope were regis-
tered; these were probably due to the high summer tem-
peratures combined with emotional factors (especially 
in the case of an adolescent). Following the first minor 
events, all vaccinees were strongly recommended to 
leave their car windows open.
In 2019, too, no major adverse events were reported, 
whereas 20 minor events occurred: headache, paresthe-
sia, pre-syncope and syncope.
Conclusions
To our knowledge, this is the first case-report on anti-
TBE vaccination carried out by means of the drive-
through modality during a worldwide pandemic.
The experience of the Local Health Unit “AULSS 1 
Dolomiti” in the Province of Belluno indicates that this 
innovative modality is a safe and efficient means of vac-
cinating large numbers of people while still maintaining 
social distancing.
According to the literature, drive-through vaccination 
has been implemented in some other countries, though 
almost exclusively for mass immunization against sea-
sonal influenza. Specifically, in the USA, drive-through 
vaccinations were first carried out more than 20 years 
ago in Kentucky  [6,  13-14], and have been repeated 
yearly ever since. In North Carolina [15] and New Mex-
ico  [16,  17] flu vaccines have also been occasionally 
administered in the drive-through modality in the last 
two decades. In these and other [18] American contexts, 
drive-through vaccination proved successful in immu-
nizing local communities against seasonal influenza.
During the current COVID-19 pandemic, drive-through 
vaccination has become more common and is now being 
adopted in several contexts. In New South Wales, Aus-
tralia, for instance, local health authorities have drawn 
up guidelines for general practitioners who choose the 
drive-through option for seasonal influenza vaccina-
tion [19]. In terms of logistics, pre-vaccination arrange-
ments (appointments, anamnestic assessment), safety 
precautions and emergency equipment, these guidelines 
are comparable to those issued by the Local Health Unit 
“AULSS 1 Dolomiti” in Belluno. 
In Europe, the British National Health Service provid-
ed drive-through vaccination against measles-mumps-
rubella and papillomavirus for adolescents during the 
summer [20].
Moreover, analysis of the trend in anti-TBE vaccina-
tions in the Province of Belluno reveals that the number 
of people requesting vaccination has steadily increased 
since this free-of-charge service was introduced in May 
2019 [11]. This indicates that the drive-through modality 
has not only proved to be a safe means of ensuring conti-
nuity of the service during a milder phase of the COVID 
pandemic, but also meets with users’ approval, despite 
the relatively few drive-through sites available (in com-
parison with the more numerous ambulatory facilities) 
and the traveling distances involved.
Finally, in the Province of Belluno, the drive-through 
modality enabled more than 100 people per session 
(3/3.5-hours) to be vaccinated through the use of on-
ly three healthcare workers and one medical doctor. 
By contrast, in a traditional indoor clinic, the current 
regulations on social distancing and sanitization of the 
clinic after each vaccination would have allowed only 
one person to be vaccinated approximately every 15 
minutes. The drive-through modality therefore proved 
able to maintain the efficiency of the service and also 
to save doctors, nurses and healthcare assistants pre-
cious hours of work in these challenging times of the 
pandemic.
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Tab. I. Number of doses of anti-TBE vaccine administered at each of 
the three sites from 24th June to 31st August 2020, and number of 
people who were vaccinated; 91 people in Belluno received both the 
first and the second doses.
Doses Subjects vaccinated
Belluno 8,193 8,284
Pieve di Cadore 2,193 2,193
Feltre 1,697 1,697
Total 12,152 12,083
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